АФАЛАЗА При поддержке препарата АФАЛАЗА

BRIDGE. How long is the pathway between Overactive Bladder and Pelvic Organ Prolapse?

15.07.2021
2076
0

Опубликована видеозапись трансляции третьего эпизода международного урологического проекта BRIDGE на тему «How long is the pathway between Overactive Bladder and Pelvic Organ Prolapse?», трансляция которого проходила 10 июля 2021 года на сайте Uro.TV.

Иностранные спикеры:

Marilena Gubbiotti - ICS member, San Donato Hospital, Pelvic Unit, Arezzo, Italy

Emanuele Rubilotta - urologist, A.O.U.I. of Verona, Dept of Urology, Italy

Stefano Rosadi - urologist, San Donato Hospital, Pelvic Unit, Arezzo

Matteo Balzarro - urologist, A.O.U.I. of Verona, Dept of Urology, Italy

Русскоязычный спикер:

Ekaterina Korshunova - neurourologist, MD, PhD, Research Center of Neurology, Central Medical Academy Administration of the President of Russian Federation, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Модератор:

Anastasia Polikarpova - urologist, SM-Clinic, Moscow, Russia

PROGRAM

Moderator: Anastasia Polikarpova

  1. Korshunova: Overactive Bladder Syndrome: what challenge does it represent today in urogynecology?
  2. Gubbiotti: Update of diagnosis and treatment of Overactive Bladder Syndrome
  3. Rubilotta: Pelvic Organ Prolapse: what do you need to know in the preoperative setting?
  4. Balzarro: Pelvic Organ Prolapse Surgery without using mesh
  5. Rosadi: Pelvic Organ Prolapse Surgery with the use of mesh

Discussion (all Panel)

  • Overactive Bladder Syndrome: does urodynamics help?  
  • Pelvic Organ Prolapse Surgery: uterus sparing surgery and use of mesh are still hot topics?

Комментарии

Важные новости